This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Bioterrorism  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2001;286:2086-2088.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2001;50:889-893

On October 4, 2001, CDC and state and local public health authorities reported a case of inhalational anthrax in Florida.¹ Additional cases of anthrax subsequently have been reported from Florida and New York City. This report updates the findings of these case investigations, which indicate that infections were caused by the intentional release of Bacillus anthracis. This report also includes interim guidelines for postexposure prophylaxis for prevention of inhalational anthrax and other information to assist epidemiologists, clinicians, and laboratorians responding to intentional anthrax exposures.

For these investigations, a confirmed case of anthrax was defined as (1) a clinically compatible case of cutaneous, inhalational, or gastrointestinal illness* that is laboratory confirmed by isolation of B. anthracis from an affected tissue or site or (2) other laboratory evidence of B. anthracis infection based on at least two supportive laboratory tests. A suspected case was defined as (1) a clinically . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Confronting Bioterrorism: Physicians on the Front Line
Varkey et al.
Mayo Clin Proc. 2002;77:661-672.
ABSTRACT